Literature DB >> 18252213

Gross deletions involving IGHM, BTK, or Artemis: a model for genomic lesions mediated by transposable elements.

Menno C van Zelm1, Corinne Geertsema, Nicole Nieuwenhuis, Dick de Ridder, Mary Ellen Conley, Claudine Schiff, Ilhan Tezcan, Ewa Bernatowska, Nico G Hartwig, Elisabeth A M Sanders, Jiri Litzman, Irina Kondratenko, Jacques J M van Dongen, Mirjam van der Burg.   

Abstract

Most genetic disruptions underlying human disease are microlesions, whereas gross lesions are rare with gross deletions being most frequently found (6%). Similar observations have been made in primary immunodeficiency genes, such as BTK, but for unknown reasons the IGHM and DCLRE1C (Artemis) gene defects frequently represent gross deletions ( approximately 60%). We characterized the gross deletion breakpoints in IGHM-, BTK-, and Artemis-deficient patients. The IGHM deletion breakpoints did not show involvement of recombination signal sequences or immunoglobulin switch regions. Instead, five IGHM, eight BTK, and five unique Artemis breakpoints were located in or near sequences derived from transposable elements (TE). The breakpoints of four out of five disrupted Artemis alleles were located in highly homologous regions, similar to Ig subclass deficiencies and Vh deletion polymorphisms. Nevertheless, these observations suggest a role for TEs in mediating gross deletions. The identified gross deletion breakpoints were mostly located in TE subclasses that were specifically overrepresented in the involved gene as compared to the average in the human genome. This concerned both long (LINE1) and short (Alu, MIR) interspersed elements, as well as LTR retrotransposons (ERV). Furthermore, a high total TE content (>40%) was associated with an increased frequency of gross deletions. Both findings were further investigated and confirmed in a total set of 20 genes disrupted in human disease. Thus, to our knowledge for the first time, we provide evidence that a high TE content, irrespective of the type of element, results in the increased incidence of gross deletions as gene disruption underlying human disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18252213      PMCID: PMC2427306          DOI: 10.1016/j.ajhg.2007.10.011

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  66 in total

1.  On the complexity measures of genetic sequences.

Authors:  V D Gusev; L A Nemytikova; N A Chuzhanova
Journal:  Bioinformatics       Date:  1999-12       Impact factor: 6.937

2.  Determination of gene organization in the human IGHV region on single chromosomes.

Authors:  N-O Chimge; S Pramanik; G Hu; Y Lin; R Gao; L Shen; H Li
Journal:  Genes Immun       Date:  2005-05       Impact factor: 2.676

3.  Genewindow: an interactive tool for visualization of genomic variation.

Authors:  Brian Staats; Liqun Qi; Michael Beerman; Hugues Sicotte; Laura A Burdett; Bernice Packer; Stephen J Chanock; Meredith Yeager
Journal:  Nat Genet       Date:  2005-02       Impact factor: 38.330

4.  Molecular characterization of the spectrum of genomic deletions in the mismatch repair genes MSH2, MLH1, MSH6, and PMS2 responsible for hereditary nonpolyposis colorectal cancer (HNPCC).

Authors:  Heleen van der Klift; Juul Wijnen; Anja Wagner; Paul Verkuilen; Carli Tops; Robyn Otway; Maija Kohonen-Corish; Hans Vasen; Cristina Oliani; Daniela Barana; Pal Moller; Celia Delozier-Blanchet; Pierre Hutter; William Foulkes; Henry Lynch; John Burn; Gabriela Möslein; Riccardo Fodde
Journal:  Genes Chromosomes Cancer       Date:  2005-10       Impact factor: 5.006

5.  An essential role for BLNK in human B cell development.

Authors:  Y Minegishi; J Rohrer; E Coustan-Smith; H M Lederman; R Pappu; D Campana; A C Chan; M E Conley
Journal:  Science       Date:  1999-12-03       Impact factor: 47.728

6.  Disruption of the BCL11B gene through inv(14)(q11.2q32.31) results in the expression of BCL11B-TRDC fusion transcripts and is associated with the absence of wild-type BCL11B transcripts in T-ALL.

Authors:  G K Przybylski; W A Dik; J Wanzeck; P Grabarczyk; S Majunke; J I Martin-Subero; R Siebert; G Dölken; W-D Ludwig; B Verhaaf; J J M van Dongen; C A Schmidt; A W Langerak
Journal:  Leukemia       Date:  2005-02       Impact factor: 11.528

7.  Uncommon Alu-mediated NF1 microdeletion with a breakpoint inside the NF1 gene.

Authors:  Cristina Gervasini; Marco Venturin; Francesca Orzan; Alessandra Friso; Maurizio Clementi; Romano Tenconi; Lidia Larizza; Paola Riva
Journal:  Genomics       Date:  2005-02       Impact factor: 5.736

8.  Severe hemophilia A due to a 1.3 kb factor VIII gene deletion including exon 24: homologous recombination between 41 bp within an Alu repeat sequence in introns 23 and 24.

Authors:  S M Nakaya; T-C Hsu; S J Geraghty; M J Manco-Johnson; A R Thompson
Journal:  J Thromb Haemost       Date:  2004-11       Impact factor: 5.824

9.  A recurrent breakpoint in the most common deletion of the Ig heavy chain locus (del A1-GP-G2-G4-E).

Authors:  A Brusco; S Saviozzi; F Cinque; A Bottaro; M DeMarchi
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

10.  Meta-analysis of gross insertions causing human genetic disease: novel mutational mechanisms and the role of replication slippage.

Authors:  Jian-Min Chen; Nadia Chuzhanova; Peter D Stenson; Claude Férec; David N Cooper
Journal:  Hum Mutat       Date:  2005-02       Impact factor: 4.878

View more
  28 in total

Review 1.  The genetic theory of infectious diseases: a brief history and selected illustrations.

Authors:  Jean-Laurent Casanova; Laurent Abel
Journal:  Annu Rev Genomics Hum Genet       Date:  2013-05-29       Impact factor: 8.929

2.  Breakpoint determination of 15 large deletions in Peutz-Jeghers subjects.

Authors:  Nicoletta Resta; Roberto Giorda; Rosanna Bagnulo; Silvana Beri; Erika Della Mina; Alessandro Stella; Marilidia Piglionica; Francesco Claudio Susca; Ginevra Guanti; Orsetta Zuffardi; Roberto Ciccone
Journal:  Hum Genet       Date:  2010-07-11       Impact factor: 4.132

3.  Enteroviral Infection in a Patient with BLNK Adaptor Protein Deficiency.

Authors:  Adeeb NaserEddin; Oded Shamriz; Baerbel Keller; Raed M Alzyoud; Susanne Unger; Paul Fisch; Evgenia Prus; Yakov Berkun; Diana Averbuch; Avraham Shaag; Adel M Wahadneh; Mary Ellen Conley; Klaus Warnatz; Orly Elpeleg; Polina Stepensky
Journal:  J Clin Immunol       Date:  2015-04-17       Impact factor: 8.317

Review 4.  New frontiers of primary antibody deficiencies.

Authors:  Mirjam van der Burg; Menno C van Zelm; Gertjan J A Driessen; Jacques J M van Dongen
Journal:  Cell Mol Life Sci       Date:  2011-11-01       Impact factor: 9.261

Review 5.  Breakpoint sites disclose the role of the V(D)J recombination machinery in the formation of T-cell receptor (TCR) and non-TCR associated aberrations in T-cell acute lymphoblastic leukemia.

Authors:  Nicole S D Larmonie; Willem A Dik; Jules P P Meijerink; Irene Homminga; Jacques J M van Dongen; Anton W Langerak
Journal:  Haematologica       Date:  2013-08       Impact factor: 9.941

6.  A hypomorphic Artemis human disease allele causes aberrant chromosomal rearrangements and tumorigenesis.

Authors:  Cheryl Jacobs; Ying Huang; Tehmina Masud; William Lu; Gerwin Westfield; William Giblin; JoAnn M Sekiguchi
Journal:  Hum Mol Genet       Date:  2010-12-08       Impact factor: 6.150

7.  Identification of CACNA1A large deletions in four patients with episodic ataxia.

Authors:  Florence Riant; Christelle Lescoat; Katayoun Vahedi; Elsa Kaphan; Annick Toutain; Thierry Soisson; Sylvette R Wiener-Vacher; Elisabeth Tournier-Lasserve
Journal:  Neurogenetics       Date:  2009-07-25       Impact factor: 2.660

Review 8.  Genetics of hypogammaglobulinemia: what do we really know?

Authors:  Mary Ellen Conley
Journal:  Curr Opin Immunol       Date:  2009-08-03       Impact factor: 7.486

9.  Genetic and epigenetic determinants mediate proneness of oncogene breakpoint sites for involvement in TCR translocations.

Authors:  N S D Larmonie; A van der Spek; A J J C Bogers; J J M van Dongen; A W Langerak
Journal:  Genes Immun       Date:  2013-12-05       Impact factor: 2.676

10.  Autosomal recessive agammaglobulinemia due to defect in μ heavy chain caused by a novel mutation in the IGHM gene.

Authors:  P Silva; A Justicia; A Regueiro; S Fariña; J M Couselo; L Loidi
Journal:  Genes Immun       Date:  2017-08-03       Impact factor: 2.676

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.